China-based Hubei Guangji Pharmaceutical Co., Ltd. (SHE: 000952) has announced a strategic partnership with Jiangnan University to establish a joint innovation laboratory. The focus of this collaboration will be on advancing the key technologies of green manufacturing and biosynthesis of functional polysaccharides and functional proteins, including human milk oligosaccharides.
Leveraging Combined Strengths for Global Exploration
The partnership aims to capitalize on the respective resource advantages of both entities, with a view to exploring new technologies and new product development on a global scale. This joint effort signifies a commitment to innovation in the pharmaceutical and biotechnological sectors, particularly in the area of green and sustainable manufacturing processes.
Significant Investment in Research and Development
Guangji Pharma has committed to providing research expenses as per a 5-year technology agreement with Jiangnan University. The investment, valued at no less than RMB10 million, underscores the company’s dedication to driving forward advancements in green manufacturing and biosynthesis. This financial commitment is expected to facilitate cutting-edge research and development, potentially leading to groundbreaking products and processes that align with global sustainability goals.-Fineline Info & Tech
